Nanomerics Ltd Employee Directory
Pharmaceutical ManufacturingEngland, United Kingdom2-10 Employees
Nanomerics Ltd applies pharmaceutical nanotechnology to accelerate medicine development, aiming to lower cost and risk while enabling new formulations of known drug compounds. The company enhances the activity and delivery of hydrophobic drugs and peptides, directing them to the right targets and modalities. Its Molecular Envelope Technology supports administration via oral and nasal routes, ocular delivery, and the ability to cross the blood-brain barrier, enabling a broad range of compounds and indications. In addition to developing its own nano-enabled medicines for ophthalmic and oral oncology applications, the firm is pursuing a peptide-based therapy for chronic pain that leverages its MET system to address limitations of current opioid therapies. Nanomerics operates in the pharmaceutical manufacturing sector and works with partners to enable specific drugs, including collaborations with a NASDAQ-listed company on two oral products and with an Asian company on nasal delivery. Based in London, England, it maintains a small team. In 2024, the company received the King's Award for Enterprise in the innovation category.